Ozempic Shreds Bones? How a Small Study Turned Into a Big Health Myth
Gizmodo • • health
Key Points:
- Recent social media myths claim GLP-1 drugs like semaglutide (Ozempic) cause severe bone damage, but these claims stem from preliminary research with low incidence rates and misinterpretations.
- Studies suggest any increased risk of osteoporosis or osteomalacia in GLP-1 users is likely due to weight loss rather than the drug itself, and doctors recommend monitoring bone health and preventative measures for at-risk patients.
- Other alleged side effects, such as muscle loss or increased suicide risk, lack strong evidence; in fact, recent research indicates semaglutide may reduce risks of depression and anxiety.
- GLP-1 drugs do have known side effects, including gastrointestinal issues and rare eye conditions, underscoring the importance of weighing benefits against risks with medical guidance.
- Despite misinformation, GLP-1 therapies have proven benefits for treating type 2 diabetes, obesity, and potentially addiction, highlighting the need for nuanced, evidence-based discussions about their use.
